Literature DB >> 22766086

My treatment approach to rheumatoid arthritis.

John M Davis1, Eric L Matteson.   

Abstract

The past decade has brought important advances in the understanding of rheumatoid arthritis and its management and treatment. New classification criteria for rheumatoid arthritis, better definitions of treatment outcome and remission, and the introduction of biologic response-modifying drugs designed to inhibit the inflammatory process have greatly altered the approach to managing this disease. More aggressive management of rheumatoid arthritis early after diagnosis and throughout the course of the disease has resulted in improvement in patient functioning and quality of life, reduction in comorbid conditions, and enhanced survival.
Copyright © 2012 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22766086      PMCID: PMC3538478          DOI: 10.1016/j.mayocp.2012.03.011

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  99 in total

1.  EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.

Authors:  M J L Peters; D P M Symmons; D McCarey; B A C Dijkmans; P Nicola; T K Kvien; I B McInnes; H Haentzschel; M A Gonzalez-Gay; S Provan; A Semb; P Sidiropoulos; G Kitas; Y M Smulders; M Soubrier; Z Szekanecz; N Sattar; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2009-09-22       Impact factor: 19.103

2.  Effects of high-intensity resistance training in patients with rheumatoid arthritis: a randomized controlled trial.

Authors:  Andrew B Lemmey; Samuele M Marcora; Kathryn Chester; Sally Wilson; Francesco Casanova; Peter J Maddison
Journal:  Arthritis Rheum       Date:  2009-12-15

Review 3.  The Simplified Disease Activity Index and Clinical Disease Activity Index to monitor patients in standard clinical care.

Authors:  Daniel Aletaha; Josef S Smolen
Journal:  Rheum Dis Clin North Am       Date:  2009-11       Impact factor: 2.670

4.  Which measure of inflammation to use? A comparison of erythrocyte sedimentation rate and C-reactive protein measurements from randomized clinical trials of golimumab in rheumatoid arthritis.

Authors:  Cynthia S Crowson; Mahboob U Rahman; Eric L Matteson
Journal:  J Rheumatol       Date:  2009-06-16       Impact factor: 4.666

Review 5.  Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis.

Authors:  Emalie Hurkmans; Florus J van der Giesen; Thea Pm Vliet Vlieland; Jan Schoones; E C H M Van den Ende
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

6.  Monitoring anti-TNFalpha treatment in rheumatoid arthritis: responsiveness of magnetic resonance imaging and ultrasonography of the dominant wrist joint compared with conventional measures of disease activity and structural damage.

Authors:  E A Haavardsholm; M Østergaard; H B Hammer; P Bøyesen; A Boonen; D van der Heijde; T K Kvien
Journal:  Ann Rheum Dis       Date:  2008-11-19       Impact factor: 19.103

Review 7.  A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis.

Authors:  Nathan Vastesaeger; Stephen Xu; Daniel Aletaha; E William St Clair; Josef S Smolen
Journal:  Rheumatology (Oxford)       Date:  2009-07-09       Impact factor: 7.580

8.  Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard.

Authors:  Alejandro Balsa; Eugenio de Miguel; Concepción Castillo; Diana Peiteado; Emilio Martín-Mola
Journal:  Rheumatology (Oxford)       Date:  2010-01-04       Impact factor: 7.580

9.  DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis.

Authors:  Y P M Goekoop-Ruiterman; J K de Vries-Bouwstra; P J S M Kerstens; M M J Nielen; K Vos; D van Schaardenburg; I Speyer; P E H Seys; F C Breedveld; C F Allaart; B A C Dijkmans
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

10.  Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors.

Authors:  R Westhovens; M Robles; A C Ximenes; S Nayiager; J Wollenhaupt; P Durez; J Gomez-Reino; W Grassi; B Haraoui; W Shergy; S-H Park; H Genant; C Peterfy; J-C Becker; A Covucci; R Helfrick; J Bathon
Journal:  Ann Rheum Dis       Date:  2009-01-05       Impact factor: 19.103

View more
  28 in total

1.  Rheumatoid arthritis - an update for general dental practitioners.

Authors:  S de Souza; R K Bansal; J Galloway
Journal:  Br Dent J       Date:  2016-11-18       Impact factor: 1.626

Review 2.  Understanding the major risk factors in the beginning and the progression of rheumatoid arthritis: current scenario and future prospects.

Authors:  Mahendra Kumar Verma; Kota Sobha
Journal:  Inflamm Res       Date:  2015-07-07       Impact factor: 4.575

3.  Characteristics of rheumatoid arthritis patients undergoing reverse shoulder arthroplasty.

Authors:  Julio J Jauregui; J Paul Hovis; S Ashfaq Hasan
Journal:  Clin Rheumatol       Date:  2017-05-24       Impact factor: 2.980

4.  ERAMRS: a new MR scoring system for early rheumatoid arthritis of the wrist.

Authors:  Fan Xiao; James F Griffith; Andrea L Hilkens; Jason C S Leung; Jiang Yue; Ryan K L Lee; David K W Yeung; Lai-Shan Tam
Journal:  Eur Radiol       Date:  2019-03-14       Impact factor: 5.315

Review 5.  Advances in the treatment of cervical rheumatoid: Less surgery and less morbidity.

Authors:  Grant W Mallory; Sasha R Halasz; Michelle J Clarke
Journal:  World J Orthop       Date:  2014-07-18

Review 6.  Perioperative management of the patient with rheumatoid arthritis.

Authors:  Megan L Krause; Eric L Matteson
Journal:  World J Orthop       Date:  2014-07-18

7.  Thirty-day complications in rheumatoid patients following total knee arthroplasty.

Authors:  Julio J Jauregui; Bhaveen H Kapadia; Anant Dixit; Qais Naziri; David J Hip-Flores; Steven F Harwin; Michael A Mont
Journal:  Clin Rheumatol       Date:  2015-08-04       Impact factor: 2.980

8.  Designation of a novel DKK1 multiepitope DNA vaccine and inhibition of bone loss in collagen-induced arthritic mice.

Authors:  Xiaoqing Zhang; Sibo Liu; Shentao Li; Yuxuan Du; Yunpeng Dou; Zhanguo Li; Huihui Yuan; Wenming Zhao
Journal:  Biomed Res Int       Date:  2015-05-05       Impact factor: 3.411

9.  A Rare Case of Cardiac Tamponade Induced by Chronic Rheumatoid Arthritis.

Authors:  Tariq Yousuf; Jason Kramer; Adam Kopiec; Zachary Bulwa; Shuvani Sanyal; Jeffrey Ziffra
Journal:  J Clin Med Res       Date:  2015-07-24

10.  "Serious skin & soft tissue infections in rheumatoid arthritis patients taking anti-tumor necrosis factor alpha drugs: a nested case-control study".

Authors:  Ngoc J Wasson; Cara D Varley; Pascal Schwab; Rongwei Fu; Kevin L Winthrop
Journal:  BMC Infect Dis       Date:  2013-11-11       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.